Vistagen Therapeutics (VTGN) Price to Earnings (2013 - 2014)
Vistagen Therapeutics' (VTGN) Price to Earnings was 19.53 for fiscal Q4 2014 (quarter ended Mar 31, 2014), down 99.3% from 2857.65 a year earlier and down 71.6% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Price to Earnings (2013 - 2014) Analysis & Trends
For FY2013 (ended Mar 31, 2013), Price to Earnings at Vistagen Therapeutics was 2851.49.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | 19.53 |
| Dec 31, 2013 | 68.71 |
| Jun 30, 2013 | 178.70 |
| Mar 31, 2013 | 2,857.65 |
API Access
Vistagen Therapeutics Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();